Description
MOR/CPR has been developed by growing the parent line, MOR, in increasing concentrations of cisplatin. The cells are cross-resistant to melphalan but show little or no cross-resistance to other platinum compounds. Cisplatin accumulation has been found to be reduced compared to the parent line.
Adherent Suspension
Aggregates in suspension
Suggested Medium
RPMI 1640 + 2mM Glutamine + 1µg/ml cisplatin + 10% Foetal Bovine Serum (FBS).
Quality Control
MOR/CPR Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
MOR/CPR Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
MOR/CPR Cell Line is for research use only
